Piramal likely to take re-entry into domestic drug market after 8 years

(G.N.S) DT. 29 Mumbai The Ajay Piramal-led Piramal Enterprises Ltd (PEL) is considering a re-entry into the domestic formulations business, eight years after selling its portfolio to US-based Abbott Laboratories. The development comes eight years after the Ajay Piramal-led conglomerate sold its portfolio to US-based Abbott Laboratories for $3.72 billion.